Contributed by Lesley Watts, Director of B-BIC Operations & Finance Intellectual property is the product of a person’s creativity and it can take several forms including patents, copyright, trademarks, and trade secrets.  Patents play a key role in innovation and economic development, particularly in the life sciences, because they allow the patent holder to capture the…

Read More

Potential for commercialization. Technology that addresses an unmet clinical need. Heart, Lung, Blood or Sleep indications. Preliminary data indicating promise of commercialization. Differentiation from competitors. IP filings, with institutions as the assignee. This event will provide you with the opportunity to pitch a team of experts on your research. You will receive immediate feedback with…

Read More

Keep pitch short and focused on the technology and its commercial application. Limit the discussion of preliminary results, and focus on the most relevant results with conclusions – not data. Present the science within the context of the business strategy. This event will provide you with the opportunity to pitch a team of experts on your research.…

Read More

Create an outline of the regulatory plan that will enable marketing approval of your technology/product. Determine which FDA division is likely to have oversight for development and approval by visiting www.fda.gov as direct consultation with the appropriate FDA Division is an essential step to ensure the smoothest possible design and conduct of a development plan…

Read More

Contributed by John Randle, Phd B-BIC COACH PRINCIPAL, RANDOM WALK VENTURES, LLC COO, KANTUM BIO   Most new technologies and products will require regulatory scrutiny and approval prior to marketing.  These requirements vary widely depending on the nature of the technology/product and their intended medical use, as well as the regulatory precedent set by existing…

Read More

A “top-down” analysis is based on current technologies or products that address the medical need your technology/product is intended to address, and the market defined by their sales figures. The bottom-up analysis starts with identification and enumeration of the specific target patient population your technology/product will address.  What is the patient population and what are…

Read More

Join us for a moderated discussion with venture capitalists and scientific entrepreneurs about the steps to take your research from inception through to commercialization. Register Here March 29, 2018      4 – 6 PM Boston Children’s Hospital Karp Research Building, 1 Blackfan Circle 4th Floor Atrium, Boston, MA 02115     The Panel Includes: Jeffrey M.…

Read More

Contributed by John Randle, Phd B-BIC COACH PRINCIPAL, RANDOM WALK VENTURES, LLC COO, KANTUM BIO As you prepare to move your technology or product out of the academic setting towards commercial development, a key step is to define the market potential for your technology/product.  Prospective investors will assess the opportunity in terms of the potential…

Read More

RECIPIENT:  Dr. Jonghan Kim TITLE: Hydrogel-based nanochelator therapy for iron overload disorders TYPE OF AWARD: Drive TECHNOLOGY TYPE: Small Molecule CLINICAL AREA: Blood INSTITUTION: Northeastern & MGH DESCRIPTION: Iron overload, best represented by hereditary hemochromatosis (primary/genetic iron overload) and transfusional hemoglobinopathy (secondary/acquired iron overload), is a well-defined risk factor for several critical diseases, including heart failure, liver cirrhosis, arthritis,…

Read More

Q:  Do I need to have slides?  A:  Pitches only need to address the suggested elements.  Use of reference materials or other visual elements is welcome if they help convey the product concept and can be shared using your laptop screen.  AV equipment will not be available. Q:  How formal will the pitches be? A:…

Read More